Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03612596 · ClinicalTrials.gov registry record · NA

Narrative Visualization for Breast Cancer Survivors' Physical Activity

A NA study of Breast Cancer, sponsored by The University of Texas Medical Branch, Galveston.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03612596: Completed NA study of Breast Cancer, sponsored by The University of Texas Medical Branch, Galveston.

NCT03612596 is a NA study of Breast Cancer that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 40 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03612596, a NA study of Breast Cancer, has completed, sponsored by The University of Texas Medical Branch, Galveston.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study tests the feasibility and acceptability of a physical activity intervention that combines use of a wearable activity monitor with a scrapbook. Half of the participants will receive this enhanced intervention, while the other half will receive a wearable activity monitor with a standard step log.

Primary Outcome

Percentage of daily workbook entries completed out of the total possible number, measured by photography of intervention materials at 12 week assessment and then assessment of each page.

Conditions Studied

Interventions

  • BEHAVIORAL Standard self-regulation
  • BEHAVIORAL Narrative visualization

Study Locations (1)

Texas

  • The University of Texas Medical Branch - Galveston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-09-01
Est. Completion 2022-03-31
Phase NA

What the finished NCT03612596 record still lists

NCT03612596 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard self-regulation is the first listed.

NCT03612596 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03612596 about?

NCT03612596 is a clinical study titled "Narrative Visualization for Breast Cancer Survivors' Physical Activity". This study tests the feasibility and acceptability of a physical activity intervention that combines use of a wearable activity monitor with a scrapbook. Half of the participants will receive this enhanced intervention, while the other half will receive a wearable activity monitor with a standard st...

What is the current status of trial NCT03612596?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-09-01. Estimated completion is 2022-03-31.

What conditions does trial NCT03612596 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT03612596?

The interventions under investigation include: Standard self-regulation (BEHAVIORAL), Narrative visualization (BEHAVIORAL).

Who is sponsoring clinical trial NCT03612596?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03612596 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03612596's enrollment target sits among peer trials

40 876th of 1224 higher than 325 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03612596, the US trial registry maintained by the National Library of Medicine. NCT03612596 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.